Concentrations of biomarkers that were significantly decreased (p < 0.05) in the cohort of cancer patients included albumin, Hb, and lymphocyte count, while white blood cell counts (WBCs), neutrophil counts, and concentrations of CXCL5 and H3Cit were comparable between patients and controls. The gene discussed is CXCL5; the disease is cancer.